Collection and Storage of Blood and Tissue Samples From Patients Who Are Undergoing Surgery For Lung Cancer
This research studies collecting and storing tissue and blood samples from patients with lung cancer who are undergoing surgery. Collecting and storing samples of tissue and blood from patients with lung cancer to study in the laboratory may help doctors learn more about changes that may occur in deoxyribonucleic acid (DNA) and identify biomarkers related to cancer.
Checked against the public recordLast updated Aug 3, 2022 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Alliance for Clinical Trials in Oncology
- Interventions being studied
- Other: cytology specimen collection procedure
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
1. Histologic Documentation: All patients with suspected or histologically documented previously untreated lung cancer undergoing surgical resection are eligible whether or not the patient participates in a CALGB-sponsored treatment trial; patients enrolled on a CALGB trial of preoperative chemotherapy for lung cancer will be eligible if a pre-treatment frozen sample of tumor (e.g., a positive lymph node from mediastinoscopy) can be submitted to the bank; patients enrolled on CALGB 140203, intraoperative sentinel node mapping in non-small cell lung cancer, are not eligible. 2. No patients with known infectious disease, such as human immunodeficiency virus (HIV), tuberculosis (TB), or hepatitis B, C
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Tunnell Cancer Center at Beebe Medical CenterLewes, Delaware
- CCOP - Christiana Care Health ServicesNewark, Delaware
- Union Hospital of Cecil CountyElkton, Maryland
- Dana-Farber/Brigham and Women's Cancer CenterBoston, Massachusetts
- Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer InstituteBoston, Massachusetts
- Masonic Cancer Center at University of MinnesotaMinneapolis, Minnesota
- Ellis Fischel Cancer Center at University of Missouri - ColumbiaColumbia, Missouri
- Siteman Cancer Center at Barnes-Jewish Hospital - Saint LouisSt Louis, Missouri
- Cancer Institute of New Jersey at Cooper - VoorheesVoorhees Township, New Jersey
- Roswell Park Cancer InstituteBuffalo, New York
- SUNY Upstate Medical University HospitalSyracuse, New York
- Veterans Affairs Medical Center - AshevilleAsheville, North Carolina
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 3, 2022. Always confirm current availability with the study team.